Piper Sandler Downgrades Achilles Therapeutics (ACHL) to Neutral

April 4, 2024 4:08 PM EDT Send to a Friend
(Updated - April 5, 2024 4:42 AM EDT)

Piper Sandler analyst Joseph Catanzaro downgraded Achilles Therapeutics (NASDAQ: ACHL) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login